Pulmonary rehabilitation in chronic obstructive pulmonary disease : outcomes in a 12 week programme by Sciriha, Anabel et al.
 Correspondence: Ms Anabel Sciriha, Room 16 Block A, Level 1, Physiotherapy, Faculty of Health Sciences, Mater Dei Hospital, Msida. Tel: 356 23401161, 
E-mail: anabel.sciriha.02@um.edu.mt 
 (Received  2  March  2015 ; accepted  28  July  2015 ) 
PR has been recommended as a key intervention for 
people with COPD (4). 
 Signifi cant gains in exercise tolerance (5–7), dys-
pnoea measures (5) and improvements in quality of 
life (8) have been observed following outpatient PR 
programmes. One of the debated issues on improve-
ments in these outcome measures arises from the 
huge variations in the time-frames for this type of 
intervention across Europe and the rest of the world 
(4,9–11). These programmes range from a duration 
of just 4 weeks (12,13) up to 18 months (14,15). 
Shorter programme durations have been documented 
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 Abstract 
 Objective. The optimal time-frame for pulmonary rehabilitation (PR) in patients diagnosed with chronic obstructive 
pulmonary disease (COPD) is still debated. A 12 week programme was designed looking at whether the benefi ts were 
reached at or before a 12 week period of PR for COPD patients.  Method . Seventy-fi ve patients (59 males, 16 females) aged 
40–75 years were referred from the local general hospital in Malta. Baseline assessments were carried out on all patients 
2 weeks before initiation of the programme. Sixty patients were eligible to start a twice-weekly, 12 week multidisciplinary 
programme delivered after the screening process. The Six-Minute Walk Test (6MWT), dyspnoea score using the Borg scale, 
spirometry testing, plethysmography, COPD Assessment Tool (CAT) score, St George ’ s Respiratory Questionnaire (SGRQ) 
and Hospital and Anxiety scale score were monitored at 4 weekly intervals throughout the 12 weeks of PR for these COPD 
patients.  Results . The 6MWT distance increased by a mean total of 132.45 m ( p   0.001) by 12 weeks, with the highest 
change recorded in the fi rst 4 weeks for the milder COPD patients. Lung function test improvements were marginal. Borg 
scale readings at rest and following exertion decreased signifi cantly from weeks 0 to 4 but remained fairly constant there-
after. The Body mass index, airway Obstruction, Dyspnoea, and Exercise capacity (BODE) index, SGRQ and CAT score 
values decreased signifi cantly throughout the weeks irrespective of the initial Medical Research Council score. Anxiety 
scoring decreased signifi cantly by 12 weeks, while the depression rating improved by 8 weeks.  Conclusion . These fi ndings 
show that 12 weeks of PR in this cohort of COPD patients resulted in clinically signifi cant changes in functional outcome 
measures which are supported by statistically signifi cant changes in health-related quality of life measures. In milder COPD 
cases, by 4 weeks of PR gains in exercise tolerance had already resulted. The more severe group required more time to 
obtain improvements. Therefore, hospitals could organize shorter PR programmes for larger numbers of patients with milder 
COPD. 
 Key words:  Anxiety ,  depression ,  duration ,  exercise tolerance ,  health-related quality of life 
 Introduction 
 This article reports a study investigating outcomes in 
a 12 week pulmonary rehabilitation (PR) programme 
for patients with chronic obstructive pulmonary dis-
ease (COPD). COPD is a major health concern. By 
the year 2020, it is estimated that COPD will be the 
third leading cause of death and fi fth leading cause of 
chronic disability worldwide (1). Patients who suffer 
from this condition make use of health services on a 
regular basis, partly because of a lack of understanding 
of their condition and partly due to their inability to 
cope with frightening and disabling symptoms (2,3). 
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periods that were comparable to those following the 
longer 7 week programme. One can postulate that 
reassessment at the 7 week time-point could have 
had a positive effect on compliance with unsuper-
vised exercise sessions at home. Andrews et  al. (21) 
looked at 363 COPD patients undergoing PR at 
three different time-points (6, 7 and 8 weeks). All 
groups included patients with a Medical Research 
Council (MRC) score of 3 or above. This study indi-
cated a statistically signifi cant improvement in the 
exercise capacity of all the participants in the three 
programmes. Those who underwent an 8 week pro-
gramme improved the most, with a 6MWT distance 
of 80 m, followed by those in the 6 week and then 
the 7 week programme (62 m and 52 m, respec-
tively). Participants enrolled in the 8 week programme 
reported better outcomes in the clinical COPD ques-
tionnaire, whereas those who underwent a 6 week 
programme had signifi cant improvement on the St 
George ’ s Respiratory Questionnaire (SGRQ). 
Andrews et  al. (21) stated that participants with a 
low health-related quality of life before PR may 
improve more than those with higher baseline levels, 
or that the programme offered to these patients may 
have been relatively short. This study included a mix 
of COPD and patients with other respiratory condi-
tions. Apart from that, although patients with differ-
ent clinical severity of disease were included, no 
analysis of how patients faired with regard to clinical 
symptoms through the course of rehabilitation was 
provided. 
 Despite the vast amount of literature available on 
PR in COPD (2–4,14,15,17,18,22,23), no consen-
sus of opinion regarding the optimal time-frame has 
yet been established (11). In the present study, we 
explore the benefi ts obtained through a 12 week PR 
programme. The potential benefi ts gained at various 
time-points throughout this intervention, at weeks 4, 
8 and 12, in people diagnosed with various severities 
of stable COPD were investigated. 
 The British Thoracic Society guidelines (4) give 
signifi cant importance to the severity aspects of 
COPD patients participating in PR programmes. 
The need for fl exible approaches to facilitate patients 
of all severities to help them to complete their reha-
bilitation is highlighted. Confl icting results are still 
found when it comes to including COPD patients in 
PR programmes with different MRC scores. Bolton 
et  al. (4) noted that COPD patients with an MRC 
score of 2 benefi t from PR with an evidence level of 
3 and those with an MRC score of 5 would benefi t 
just as well. More studies looking into the gains of 
COPD patients according to the staging of their 
disease is still required, allowing for more specifi c 
modes of training depending on the needs of these 
individuals. 
to have the probability of reducing the cost of treat-
ment per patient and to expand limited resources 
(16). On the other hand, longer duration programmes 
produce greater gains and improve the maintenance 
of benefi ts (12,14,15,17). The British Thoracic Soci-
ety guidelines for PR suggest programmes of a min-
imum of 6 weeks and a maximum of 12 weeks (4). 
 Studies by Berry et  al. (14), Foy et  al. (15), 
Troosters et  al. (17) and Guell et  al. (18) looked into 
interventions ranging from 3 to 18 months of exer-
cise training (14,15), to PR over a 6 month time-
frame (17). Guell et  al. (18) looked at a 12 month 
intervention divided into 6 months of daily rehabili-
tation followed by 6 months of weekly supervision. 
All the studies reported improvements in exercise 
tolerance, as well as a reduction in self-reported dis-
ability. No comparison of outcomes in a shorter 
time-frame was carried out, giving little indication of 
when the improvements happened. Improvements 
were reported in the fi rst 3 months, a period when 
the subjects where receiving breathing retraining 
only. The reasons for this improvement are not 
clear. 
 In a 26 week intervention, Baumann et  al. (19) 
reported signifi cant differences for most outcome 
measures [Six-Minute Walk Test (6MWT), maxi-
mum workload and health-related quality of life 
scores]. These results compare well to those of Guell 
et  al. (18) and Troosters et  al. (17), but Baumann ’ s 
intervention comprised a low-intensity weekly train-
ing programme, in contrast to other studies which 
used high-intensity training programmes. 
 Shorter programmes also reported signifi cant 
changes in outcomes. Verrill et  al. (20) and Green 
et  al. (12) showed that patients had signifi cant gains 
in exercise tolerance, dyspnoea scores and health sta-
tus after 12 weeks of PR. In the case of Verrill et  al. 
(20), an additional 12 weeks of rehabilitation resulted 
in improvements in exercise tolerance but not in 
health status or dyspnoea outcomes. This suggests 
that the programme duration may not have an equal 
impact on all of the outcome measures. Green et  al. 
(12) reported improvements in a 7 week programme 
as opposed to a 4 week intervention. However, the 
latter group of participants were not reassessed again 
at the 7 week time-point, not allowing one to deter-
mine whether the results obtained at 7 weeks were 
caused by some delaying effect. The study by Green 
et  al. (12) was readdressed by Sewell et  al. (13) in 
2006, who studied 100 patients with moderate to 
severe COPD. This time, patients who were in the 
4 week training group were also examined at 7 weeks. 
All patients reported signifi cant improvements in 
exercise tolerance and health status. Participants in 
the 4 week programme had gains in exercise toler-
ance at both the 7 week and 6 month follow-up 
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 Method 
 This article reports a longitudinal, observational type 
of study. Data obtained from this study were recorded 
at baseline, after 4 weeks (eight sessions), after 
8 weeks (12 sessions) and after 12 weeks (24 sessions) 
of PR. Participants were then followed up at 
weeks 28 and 52 on completion of the PR 
programme, although the last two periods are beyond 
the scope of this paper. Comparisons have been 
made among times, with each patient serving as his 
or her own control. 
 Participants 
 Seventy-fi ve patients (59 males, 16 females) with a 
confi rmed diagnosis of COPD were referred from 
the medical wards and respiratory outpatient clinic 
of the local general hospital in Malta. The defi nition 
of COPD adopted for this study was that provided 
by American Thoracic Society/European Respiratory 
Society guidelines (24). Patients had a self-reported 
smoking history, clinical signs and symptoms, 
together with spirometry readings that were consis-
tent with COPD and exertional dyspnoea (MRC 
grade 2 or above). These participants were all found 
to be medically stable by the respiratory physicians 
and pharmacological treatment was assured to be 
optimal. This remained consistent throughout the 
PR programme. Eight participants did not meet the 
inclusion criteria [unstable ischaemic heart disease 
( n    2), diagnosis of lung cancer ( n    1), presence 
of mobility problems affecting participation ( n    3) 
and lack of transport ( n    2)]. Another seven patients 
did not accept to participate in the PR programme 
for various personal reasons. 
 Sixty patients agreed to participate in this study 
after having been assessed by medical doctors and a 
physiotherapist. The inclusion criteria were oxygen 
saturations of    92% at rest, willingness to partici-
pate in the rehabilitation classes, stable cardiovascu-
lar system and no neurological or orthopaedic 
problems which could interfere with rehabilitation. 
Each participant was provided with written informa-
tion about the programme and invited to join in this 
study. Those who did not meet the criteria were given 
an appointment for respiratory physiotherapy within 
the hospital department. Consenting participants 
were enrolled into a 12 week PR programme. How-
ever, participants who required modifi cations to their 
drug therapy owing to exacerbations were excluded 
from the study. 
 Measurements 
 Patients were assessed 2 weeks before enrolling on 
the programme and then at 4 weekly intervals 
throughout the intervention. The following outcomes 
were measured: spirometry, 6MWT, Borg scale, 
SGRQ, Body mass index, airway Obstruction, 
Dyspnoea, and Exercise capacity (BODE) index, 
Hospital and Anxiety (HAD) scale score and COPD 
Assessment Tool (CAT) score. Each participant was 
classifi ed according to the MRC dyspnoea scale, 
placing them into one of fi ve categories, i.e. 1 to 5, 
according to self-perceived breathlessness during 
daily activities (25). 
 To complement the MRC scale, the BODE index 
was also measured. This index measures disease 
severity based on the body mass index, degree of 
airway obstruction measured by forced expiratory 
volume in one second (FEV 1 ), dyspnoea assessed by 
the MRC scale and exercise capacity measured by 
the 6MWT. Each component is given an index, with 
the total score ranging from 0 to 10 points. Higher 
scores indicate greater severity (26). 
 Exercise tolerance rating.  The 6MWT was performed 
according to American Thoracic Society guidelines 
(27). Each patient was instructed to walk as rapidly 
as possible in a 30 m corridor for 6 min. The test was 
repeated twice with an interval of 30 min. The lon-
gest distance on a 6MWT and oxygen saturation 
were utilized to measure exercise capacity. Dyspnoea 
was scored using the Borg Category Ratio scale (28) 
to measure symptoms during exercise before and 
after the test. 
 St George ’ s Respiratory Questionnaire. The SGRQ is a 
widely used questionnaire owing to its specifi city to 
respiratory diseases. This questionnaire consists of 
50 items, separated into three parts: symptoms 
(distress due to respiratory symptoms), activities 
(effects due to impairment of mobility or physical 
activity) and effects (psychosocial effects of the dis-
ease). The scores range from 0 to 100 for the three 
subscales, with a summary total score. Higher scores 
indicate worse health status; 0 indicates no impair-
ment and 100 indicates maximal impairment (29). 
The SGRQ has been shown to have an adequate 
interrater reliability and reproducibility as well as the 
ability to quantify change over time (29). 
 COPD Assessment Tool.  The CAT tool looks into 
symptoms, presenting two statements for each symp-
tom which describe the best (score of 0) and worst 
(score of 5) self-assessment for that statement 
(29,30). The scores for each of the eight items are 
then added up, giving one fi nal score (with a mini-
mum of 0 and maximum score of 40) (31,32). The 
higher the value of this score, the worse the health 
status of the individual. This score has a high internal 
consistency (Cronbach ’ s  a  5  0.88) as well as repro-
ducibility (intraclass correlation coeffi cient    0.80). 
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 Hospital Anxiety and Depression score.  The HAD scale 
has been specifi cally developed for the recognition of 
anxiety and depression in patients with somatic con-
ditions. It is a validated tool which looks into the 
symptom severity in patients with chronic diseases 
who have anxiety and depressive related signs (33,34). 
The HAD scale is divided into an anxiety (HADS-A) 
and a depression subscale (HADS-D), each of which 
contains seven items rated 0–3, with the highest pos-
sible score for each domain being 21. Scores less than 
8 indicate no clinical distress, scores between 8 and 
10 indicate possible psychiatric morbidity, and scores 
of 11 or more indicate pathological levels of distress 
(34). The HAD score has been widely used and 
translated in several countries and has demonstrated 
reliability and validity when used to assess medical 
patients (34). 
 Intervention 
 A multidisciplinary PR programme was delivered 
twice weekly for 12 weeks. Each class was of 2 h 
duration, with the fi rst hour consisting of exercises 
made up of 5 min warm-up, walking on a treadmill, 
the speed of which was devised from the 6MWT and 
the time gradually increased throughout the weeks; 
step-climbing, arm ergometry, cycling using a sta-
tionary bike, and strength training for the upper and 
lower limbs using weights. Inspiratory muscle train-
ing was carried out using the Respironics IMT 
Threshold trainer  ®  for 15 min during the class. All 
participants were asked to carry this out at home for 
30 min of training 5 days per week over and above 
the additional general exercise recommended below. 
The following educational sessions covered various 
aspects of COPD care and self-management by med-
ical doctors, psychologists, physiotherapists, dieti-
cians and respiratory nurses. Patients also received 
an individualized home exercise programme consist-
ing of exercise similar to what was being carried out 
during the classes. Each participant was encouraged 
to perform at least 20 min of these exercises per day. 
These sessions were monitored by a home diary sys-
tem provided to each participant at the start of the 
programme. 
 Ethical considerations 
 Informed consent was requested and the possibility 
to quit the programme was allowed if the participants 
so desired. All data collected about the participants 
were coded to ensure patient confi dentiality, with the 
information collected being used only for the 
purposes of the study. Ethical approval was obtained 
from the University of Malta Research Ethics 
Committee. 
 Statistical analysis 
 Statistical analysis was carried out using Statistical 
Package for Social Science (SPSS) software, version 22. 
Baseline characteristics and exercise data are presented 
as mean   SD. Differences in the outcome measures 
were compared using repeated measures analysis of 
variance, and where analysis of variance identifi ed a 
signifi cant difference,  post hoc tests were computed. The 
mean difference and 95% confi dence interval (CI) are 
presented where necessary. A  p value    0.05 was con-
sidered statistically signifi cant. 
 Results 
 Out of the 60 patients recruited for this study, 
49 patients completed the full programme (43 males, 
six females). Three participants stopped after 4 weeks 
as they were fi nding no benefi t in participation and 
two had to suspend their rehabilitation after 8 weeks 
for personal reasons. Their mean age was 66   
7.76 years, weight 75    14.97 kg and height 
164    7.54 cm. Thirty-one per cent ( n    15) of the 
subjects were classifi ed with an MRC score of 2, 29% 
an MRC of 3 ( n    14), and 20% ( n    10) each with 
an MRC of 4 and 5. It was only for statistical pur-
poses that the patients were divided into MRC groups 
as mild to moderate (MRC 2–3) and severe and very 
severe (MRC 4–5). 
 Comparing results before and after the rehabilita-
tion phase, no signifi cant effects on any of the pul-
monary function tests were noted. However, signifi cant 
improvements were obtained in exercise tolerance 
and quality of life measures. 
 Six-Minute Walk Test 
 Signifi cant improvements in the 6MWT distance were 
recorded for all the cohort of patients taken together 
after 12 weeks of rehabilitation, with a total change of 
138.91 m ( p   0.001). Through  post hoc analysis using 
Bonferroni corrections, the most signifi cant changes 
in the whole group were registered in the fi rst 4 weeks 
(mean total increase of 68.54    91.62 m;  p   0.001). 
Patients with a mild to moderate severity (MRC 2–3) 
registered a signifi cant increase of 126.96 m (32%; 
 p   0.001), with most of the improvement happening 
during the fi rst 4 weeks of rehabilitation (61.43    78.34 
m difference;  p   0.001). Subjects in the severe to very 
severe category (MRC 4–5) registered a lower per-
centage improvement, but still had a signifi cant change 
after 12 weeks of rehabilitation, with an increase of 
164.61 m (58%) in distance ( p    0.007).  Post hoc anal-
ysis of this group registered no signifi cant changes at 
the 4 and 8 week time-points compared to baseline 
(Figure 1). 
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 The changes in exercise tolerance also resulted in 
signifi cant decreases in the dyspnoea ratings following 
the exercise tolerance test, from 3.49    1.93 to 
1.90    1.56 ( p   0.001). This drop was most marked 
in the fi rst 4 weeks ( p    0.026), corresponding with 
the improvement in exercise tolerance. This change 
was also noted for patients with an MRC score of 2–3 
after 12 weeks ( p    0.027). Participants with an MRC 
score of 4–5 registered a signifi cant drop on the Borg 
scale ( p    0.037). Dyspnoea rating at rest registered 
a signifi cant drop after 8 weeks of rehabilitation, from 
a score of 0.93    1.33 to 0.05    0.31 ( p    0.002). It 
was only the patients in the most severe group who 
registered a signifi cant drop in dyspnoea ratings at rest 
by the 8th week of rehabilitation, from a mean total 
of 1.46    1.33 to 0    0 at the 8th week ( p    0.028). 
 Health-related quality of life 
 Signifi cant improvements in health-related quality of 
life measures were noted as early as the fi rst 4 weeks 
for the total SGRQ score ( p   0.001). Participants with 
an MRC score of 2–3 registered a signifi cant change in 
the total score after the 8th week ( p    0.001). Those 
with a higher MRC score registered signifi cant changes 
as early as 4 weeks of rehabilitation, from a mean total 
of 51.79    13.30 to 42.14    13.59. This continued to 
signifi cantly improve through the weeks for both groups 
 Figure 1. Graph showing the changes in the Six-Minute Walk Test for the whole group and the subgroups with Medical Research Council 
(MRC) score 2-3 and MRC 4-5. Time-points that registered a statistically signifi cant change have been noted. 
 Figure 2. Graph showing the changes in the Total St George ’ s Respiratory Questionnaire score for the whole group and the subgroups with 
Medical Research Council (MRC) score 2-3 and MRC 4-5. Time-points that registered a statistically signifi cant change have been noted. 
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(Figure 2). Looking at all the different SGRQ domains, 
the whole group also registered signifi cant changes by 
the 4th week of rehabilitation, in the activity score 
( p    0.001) and the impact and symptom scores 
( p    0.020 and  p    0.002, respectively). Those with an 
MRC score of 2–3 required 12 weeks of rehabilitation 
to register a change in the activity score ( p    0.001). 
The more severe group required less time (8 weeks) to 
register a change in this domain ( p   0.001). Changes 
in the impact score were registered after the 8th week 
for both groups ( p   0.001 and  p    0.031, respec-
tively). The more severe patients registered signifi cant 
changes by the 4th week in their symptom scoring 
( p    0.048), as opposed to  p    0.023 for the milder 
group. 
 A signifi cant drop in ratings for the CAT score in 
the whole group, as well as for the subgroups, resulted 
from this PR programme. The whole cohort of 
patients, as well as the subgroups (MRC 2–3 and 
MRC 4–5), registered a change as early as the fi rst 
4 weeks of rehabilitation ( p   0.001,  p   0.001 and 
0.042, respectively). 
 Anxiety and depression ratings 
 Signifi cant changes in the anxiety and depression rat-
ings were recorded after 8 weeks of rehabilitation 
( p    0.001) for both cases. Participants with a severe 
and very severe COPD rating did not have any signifi -
cant changes throughout the programme when looking 
at their anxiety ratings, as opposed to the milder group 
of patients who had signifi cant changes after 3 weeks 
of rehabilitation ( p    0.024). Participants with an MRC 
score of 2–3 had signifi cant changes in depression rat-
ings after 12 weeks of rehabilitation ( p    0.013), but 
the more severe group registered earlier changes by the 
8th week ( p    0.013). 
 Body mass index, airway Obstruction, Dyspnoea, and 
Exercise capacity index 
 Signifi cant changes in the BODE index resulted in 
the whole group as well as the subgroups by the 
8th week ( p   0.001 for the whole group,  p    0.002 
for the subjects with an MRC 2–3 and  p   0.001 for 
the more severe group). 
 Table I documents the signifi cant changes in the 
various measures of both the physiological and quality 
of life outcomes obtained during the PR programme 
for the patients with different severities of COPD. 
 Discussion 
 There is currently no consensus regarding the opti-
mal length of a PR programme for patients with 
chronic respiratory conditions. This study shows that 
following a 4 week rehabilitation programme, patients 
with a milder form of COPD (MRC 2–3) had marked 
improvements in their exercise tolerance measures, 
which were then followed up with further improve-
ments in these measures extending through the fol-
lowing 8 weeks of this programme. This also led to 
changes in health-related quality of life measures. 
Those with a more severe form of COPD required 
more time, 12 weeks or slightly longer, to obtain 
amelioration in functional improvements. These 
severe patients (MRC 4–5) took longer to increase 
their exercise tolerance levels, but by the 12th week 
of rehabilitation there was a signifi cance increase of 
136.25 m in their 6MWT, that is, a 48% change in 
distance from the start ( p   0.001). 
 On the other hand, changes in health-related 
quality of life measures for the more severe group 
were reported earlier than in the milder group. These 
changes did not affect the anxiety levels that the more 
severe group of patients were reporting at baseline. 
 These fi ndings correspond well with studies that 
have looked into these outcome measures irrespec-
tive of the duration of the programme (5–21). To our 
knowledge, aspects of outcomes according to COPD 
severity have not been looked into in such detail. The 
benefi ts of PR were assessed per individual MRC 
score and the exact time-points at which these sig-
nifi cant changes in outcomes occurred are being 
reported here for the fi rst time. 
 Changes recorded in the walking distance 
achieved by the subjects in this study can be attrib-
uted to the mastering of dyspnoea when carrying out 
functional activities throughout the 12 week PR pro-
gramme. Gains in distance and adaptations towards 
exercise probably occurred as a result of improved 
physical status and an altered response to exercise, 
both of which aid in the control of breathlessness. 
Other physiological changes such as better cardiac 
adaptation, decreased lactic acid production and 
reduction in the metabolic cost of exercise all con-
tribute to these functional improvements (35). 
 Taken together, all participants had achieved sig-
nifi cant changes in both their resting and exertional 
Borg ratings by the fi rst 4 weeks of the intervention. 
The different subgroups needed 12 weeks of reha-
bilitation to achieve statistically signifi cant improve-
ments in exertional dyspnoea levels, with the milder 
group registering better changes. 
 Lung function test changes through the 12 weeks 
of rehabilitation were marginal, despite the addition 
of the inspiratory muscle trainer. These fi ndings are 
consistent with many other studies which have looked 
at lung function changes in COPD patients after PR 
(1–3,17). A possible cause for lack of change in this 
area, both in this study as well as in others, could 
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relate to the fact that the respiratory muscles of 
COPD patients are affected by several comorbid fac-
tors related to both the presence and severity of 
COPD. These factors cause impairments in the 
structure and function of the respiratory muscles. 
 Using the SGRQ to assess the effects of PR on 
quality of life, the study identifi ed changes in all 
domains as early as 4 weeks after commencing the 
programme. Further signifi cant changes were regis-
tered as the programme progressed. Participants 
with a milder form of COPD took longer to register 
changes in the quality of life measures. Those with 
an MRC score of 2–3 registered a signifi cant change 
after the 8th week ( p    0.001) while those with a 
higher MRC score registered signifi cant changes 
from as early as the 4th week, from a mean total of 
51.10    14.07 to 40.83    15.13. This continued to 
signifi cantly improve through the weeks of rehabilita-
tion for both groups. Participants with an MRC 
score of 2–3 obtained signifi cant improvements in 
the activity score after 12 weeks of rehabilitation 
( p   0.001), whereas the more severe group regis-
tered a signifi cant change before this, that is, follow-
ing the 3rd week ( p   0.001). 
 Quality of life scores such as the SGRQ identifi ed 
signifi cant symptom amelioration and functional 
performance. The improvements started being 
reported by the 4th week but were further enhanced 
mostly at the 8th week. This improvement was surely 
affected by the progress seen in anxiety and depres-
sion scores. In the most severe patients, it was impres-
sive to see that there was a marked change in 
depressive mood by 12 weeks of PR. Since depres-
sion is one of the most disabling complaints of these 
patients, this progress must surely change the com-
plete outlook of these patients towards their quality 
of life and respiratory condition. 
 Limitations of the study 
 Some possible shortcomings that may have infl u-
enced the end results include the number of partici-
pants in each group together with the lack of 
compliance by some of them towards the home exer-
cise programme. Various studies have shown that 
meaningful changes in distance covered during the 
6MWT may be infl uenced by a number of factors, 
such as sociocultural factors and the level of physical 
activity before and during the programme. 
 Conclusion 
 In conclusion, we have seen that this PR programme 
was of benefi t to our group of patients with different 
severities of COPD. Patients with mild disease had 
more marked improvements in functional measures 
as early as 4 weeks but continued to improve with 
further rehabilitation. In the more severe COPD 
group of patients, this improvement in functional 
performance occurred at a later time-point but their 
improvement in quality of life measures was more 
impressive. These results indicate that PR services 
should be offered to patients according to the sever-
ity of their COPD. There is an indication that patients 
with a milder form or COPD require less time to 
achieve functional changes but need more input to 
help to translate this into quality of life gains. This 
may have an impact both at an individual level and 
at a global organizational and fi nancial level. Such 
subdivisions of PR programmes could also result in 
institutions being able to carry out shorter pro-
grammes on bigger numbers of patients with mild 
COPD concurrently. 
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